Back
ALX Oncology Holdings 10K Form
Sell
44
ALXO
ALX Oncology Holdings
Last Price:
1.41
Seasonality Move:
14.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-18 | 10K | ALXO/ALX Oncology Holdings Annual |
| 2020-11-12 | 10Q | ALXO/ALX Oncology Holdings Quarterly |
| 2020-08-27 | 10Q | ALXO/ALX Oncology Holdings Quarterly |
Receive ALXO News And Ratings
See the #1 stock for the next 7 days that we like better than ALXO
ALXO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.18M |
|---|---|
| Cash Flow: | $-25.53M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.59 |
| Price / Book: | 0.5 |
Profitability
| EPS (TTM): | -2.97000 |
|---|---|
| Net Income (TTM): | $-151.16M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
ALX Oncology Holdings Earnings Forecast
Key ALX Oncology Holdings Financial Ratios
- The Selling, General & Administrative Expenses for ALXO have been equal to 1,252.88% of Gross Profit Margin.
- The Interest Expense is -0.97% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 1 years.
ALX Oncology Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALXO |
| Website: | alxoncology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALXO Technical Analysis vs Fundamental Analysis
Sell
44
ALX Oncology Holdings (ALXO)
is a Sell
Is ALX Oncology Holdings a Buy or a Sell?
-
ALX Oncology Holdings stock is rated a Sell
The current ALX Oncology Holdings [ALXO] share price is $1.29. The Score for ALXO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.